Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,002 | -1,493 | -949 | -5,728 | -5,514 |
| Accounts receivable | N/A | -199 | 49 | 13 | -20 |
| Other Working Capital | -917 | -845 | -254 | -345 | -357 |
| Other Operating Activity | 286 | 405 | 227 | 1,193 | 1,744 |
| Operating Cash Flow | $-2,633 | $-2,132 | $-927 | $-4,867 | $-4,147 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 0 | 315 | 0 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $315 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,782 | 21 | 21 | 5,083 | 4,796 |
| Other Financing Activity | -300 | -300 | 0 | 2,167 | 2,728 |
| Financing Cash Flow | $1,482 | $-279 | $21 | $7,250 | $7,524 |
| Beginning Cash Position | 3,324 | 3,324 | 3,324 | 626 | 626 |
| End Cash Position | 2,173 | 913 | 2,418 | 3,324 | 4,003 |
| Net Cash Flow | $-1,151 | $-2,411 | $-906 | $2,698 | $3,377 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,633 | -2,132 | -927 | -4,867 | -4,147 |
| Free Cash Flow | -2,633 | -2,132 | -927 | -4,867 | -4,147 |